Abstract
Smad anchor for receptor activation (SARA or ZFYVE9) has been proposed to mediate transforming growth factor β (TGF-β) signaling by direct interaction with the non-activated Smad proteins and the TGF-β receptors; however, these findings are controversial. We demonstrate no correlation between SARA expression and the levels of TGF-β-induced phosphorylation of Smads in various B-cell lymphomas. Moreover, knockdown of SARA in HeLa cells did not interfere with TGF-β-induced Smad activation, Smad nuclear translocation, or induction of TGF-β target genes. Various R-Smads and TGF-β receptors did not co-immunoprecipitate with SARA. Collectively, our results demonstrate that SARA is dispensable for functional TGF-β-mediated signaling.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Cell Line, Tumor
-
Gene Knockdown Techniques
-
HeLa Cells
-
Humans
-
Intracellular Signaling Peptides and Proteins / antagonists & inhibitors
-
Intracellular Signaling Peptides and Proteins / genetics
-
Intracellular Signaling Peptides and Proteins / metabolism*
-
Lymphoma, B-Cell / metabolism
-
Phosphorylation
-
RNA, Small Interfering / genetics
-
Receptors, Transforming Growth Factor beta / metabolism
-
Recombinant Proteins / pharmacology
-
Serine Endopeptidases / genetics
-
Serine Endopeptidases / metabolism*
-
Signal Transduction / drug effects
-
Smad Proteins, Receptor-Regulated / metabolism
-
Transforming Growth Factor beta1 / metabolism*
-
Transforming Growth Factor beta1 / pharmacology
Substances
-
Intracellular Signaling Peptides and Proteins
-
RNA, Small Interfering
-
Receptors, Transforming Growth Factor beta
-
Recombinant Proteins
-
Smad Proteins, Receptor-Regulated
-
Transforming Growth Factor beta1
-
ZFYVE16 protein, human
-
Serine Endopeptidases